Howard L. Weiner - Publications

Affiliations: 
Neuroimmunology Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States 
Website:
http://weinerlab.bwh.harvard.edu/members/WeinerLab_Weiner.html

223 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Aschenbrenner D, Foglierini M, Jarrossay D, Hu D, Weiner HL, Kuchroo VK, Lanzavecchia A, Notarbartolo S, Sallusto F. Publisher Correction: An immunoregulatory and tissue-residency program modulated by c-MAF in human T17 cells. Nature Immunology. PMID 30448856 DOI: 10.1038/s41590-018-0264-2  0.32
2018 Aschenbrenner D, Foglierini M, Jarrossay D, Hu D, Weiner HL, Kuchroo VK, Lanzavecchia A, Notarbartolo S, Sallusto F. An immunoregulatory and tissue-residency program modulated by c-MAF in human T17 cells. Nature Immunology. PMID 30201991 DOI: 10.1038/s41590-018-0200-5  0.32
2018 Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron. 97: 742-768. PMID 29470968 DOI: 10.1016/j.neuron.2018.01.021  0.4
2016 Mayo L, Cunha AP, Madi A, Beynon V, Yang Z, Alvarez JI, Prat A, Sobel RA, Kobzik L, Lassmann H, Quintana FJ, Weiner HL. IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation. Brain : a Journal of Neurology. PMID 27246324 DOI: 10.1093/brain/aww113  0.8
2016 Kuhn C, Weiner HL. Immunology. How does the immune system tolerate food? Science (New York, N.Y.). 351: 810-1. PMID 26912876 DOI: 10.1126/science.aaf2167  0.8
2016 Liu S, da Cunha AP, Rezende RM, Cialic R, Wei Z, Bry L, Comstock LE, Gandhi R, Weiner HL. The Host Shapes the Gut Microbiota via Fecal MicroRNA. Cell Host & Microbe. 19: 32-43. PMID 26764595 DOI: 10.1016/j.chom.2015.12.005  0.8
2015 Mazzola MA, Raheja R, Murugaiyan G, Rajabi H, Kumar D, Pertel T, Regev K, Griffin R, Aly L, Kivisakk P, Nejad P, Patel B, Gwanyalla N, Hei H, Glanz B, ... ... Weiner HL, et al. Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation. Journal of Neuroinflammation. 12: 245. PMID 26714756 DOI: 10.1186/s12974-015-0460-z  0.8
2015 Rezende RM, da Cunha AP, Kuhn C, Rubino S, M'Hamdi H, Gabriely G, Vandeventer T, Liu S, Cialic R, Pinheiro-Rosa N, Oliveira RP, Gaublomme JT, Obholzer N, Kozubek J, Pochet N, ... ... Weiner HL, et al. Identification and characterization of latency-associated peptide-expressing γδ T cells. Nature Communications. 6: 8726. PMID 26644347 DOI: 10.1038/ncomms9726  0.8
2015 Tauhid S, Chu R, Sasane R, Glanz BI, Neema M, Miller JR, Kim G, Signorovitch JE, Healy BC, Chitnis T, Weiner HL, Bakshi R. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis. Journal of Neurology. PMID 26205635 DOI: 10.1007/s00415-015-7853-x  0.8
2015 Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CR, Bakshi R, Healy BC. Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis. Neuroimage. PMID 26093330 DOI: 10.1016/j.neuroimage.2015.06.037  0.8
2015 Murugaiyan G, da Cunha AP, Ajay AK, Joller N, Garo LP, Kumaradevan S, Yosef N, Vaidya VS, Weiner HL. MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. The Journal of Clinical Investigation. 125: 1069-80. PMID 25642768 DOI: 10.1172/JCI74347  0.8
2015 Bhela S, Kempsell C, Manohar M, Dominguez-Villar M, Griffin R, Bhatt P, Kivisakk-Webb P, Fuhlbrigge R, Kupper T, Weiner H, Baecher-Allan C. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. Journal of Immunology (Baltimore, Md. : 1950). 194: 2180-9. PMID 25637022 DOI: 10.4049/jimmunol.1303257  0.8
2015 Rotstein DL, Healy BC, Malik MT, Chitnis T, Weiner HL. Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. Jama Neurology. 72: 152-8. PMID 25531931 DOI: 10.1001/jamaneurol.2014.3537  0.8
2015 da Cunha AP, Wu HY, Rezende RM, Vandeventer T, Weiner HL. In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance. International Immunology. 27: 73-82. PMID 25194146 DOI: 10.1093/intimm/dxu083  0.8
2015 Chua AS, Egorova S, Anderson MC, Polgar-Turcsanyi M, Chitnis T, Weiner HL, Guttmann CRG, Bakshi R, Healy BC. Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models Neuroimage: Clinical. 8: 606-610. DOI: 10.1016/j.nicl.2015.06.009  0.8
2014 Quintana FJ, Patel B, Yeste A, Nyirenda M, Kenison J, Rahbari R, Fetco D, Hussain M, O'Mahony J, Magalhaes S, McGowan M, Johnson T, Rajasekharan S, Narayanan S, Arnold DL, ... Weiner HL, et al. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis. Neurology. 83: 2219-26. PMID 25381299 DOI: 10.1212/WNL.0000000000001066  0.8
2014 Tauhid S, Neema M, Healy BC, Weiner HL, Bakshi R. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis. Journal of the Neurological Sciences. 346: 250-4. PMID 25220114 DOI: 10.1016/j.jns.2014.08.047  0.8
2014 Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, ... Weiner HL, et al. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2. Neuroreport. 25: 1156-61. PMID 25100554 DOI: 10.1097/WNR.0000000000000244  0.8
2014 Kivisäkk P, Francois K, Mbianda J, Gandhi R, Weiner HL, Khoury SJ. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. Plos One. 9: e103716. PMID 25075741 DOI: 10.1371/journal.pone.0103716  0.8
2014 Glanz BI, Musallam A, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Treatment satisfaction in multiple sclerosis. International Journal of Ms Care. 16: 68-75. PMID 25061430 DOI: 10.7224/1537-2073.2013-021  0.8
2014 Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, Wu PM, Doykan CE, Lin J, Cotleur AC, Kidd G, Zorlu MM, Sun N, Hu W, Liu L, ... ... Weiner HL, et al. Differential roles of microglia and monocytes in the inflamed central nervous system. The Journal of Experimental Medicine. 211: 1533-49. PMID 25002752 DOI: 10.1084/jem.20132477  0.8
2014 Kothare SV, Singh K, Chalifoux JR, Staley BA, Weiner HL, Menzer K, Devinsky O. Severity of manifestations in tuberous sclerosis complex in relation to genotype. Epilepsia. 55: 1025-9. PMID 24917535 DOI: 10.1111/epi.12680  0.8
2014 Malik MT, Healy BC, Benson LA, Kivisakk P, Musallam A, Weiner HL, Chitnis T. Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis. Neurology. 82: 2173-9. PMID 24850491 DOI: 10.1212/WNL.0000000000000524  0.8
2014 Kothare SV, Singh K, Hochman T, Chalifoux JR, Staley BA, Weiner HL, Menzer K, Devinsky O. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations. Epilepsia. 55: 1020-4. PMID 24754401 DOI: 10.1111/epi.12627  0.8
2014 Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R, Weiner H, De Jager PL, Miller KK, Chitnis T. Low testosterone is associated with disability in men with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1584-92. PMID 24710799 DOI: 10.1177/1352458514527864  0.8
2014 Levy Barazany H, Barazany D, Puckett L, Blanga-Kanfi S, Borenstein-Auerbach N, Yang K, Peron JP, Weiner HL, Frenkel D. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE. Experimental Neurology. 255: 63-70. PMID 24552689 DOI: 10.1016/j.expneurol.2014.02.010  0.8
2014 Ruppe V, Dilsiz P, Reiss CS, Carlson C, Devinsky O, Zagzag D, Weiner HL, Talos DM. Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex. Epilepsia. 55: 539-50. PMID 24512506 DOI: 10.1111/epi.12545  0.8
2014 Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, ... ... Weiner HL, et al. Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nature Neuroscience. 17: 131-43. PMID 24316888 DOI: 10.1038/nn.3599  0.8
2014 Harter DH, Bassani L, Rodgers SD, Roth J, Devinsky O, Carlson C, Wisoff JH, Weiner HL. A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. Journal of Neurosurgery. Pediatrics. 13: 21-8. PMID 24180681 DOI: 10.3171/2013.9.PEDS13193  0.8
2014 Roth J, Carlson C, Devinsky O, Harter DH, Macallister WS, Weiner HL. Safety of staged epilepsy surgery in children. Neurosurgery. 74: 154-62. PMID 24149978 DOI: 10.1227/NEU.0000000000000231  0.8
2014 Kivisäkk P, Healy BC, Francois K, Gandhi R, Gholipour T, Egorova S, Sevdalinova V, Quintana F, Chitnis T, Weiner HL, Khoury SJ. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 438-44. PMID 24005026 DOI: 10.1177/1352458513503052  0.8
2014 Tran HC, Gardner S, Weiner HL, Liebes LF, Finlay JL. Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners. 20: 229-32. PMID 23929729 DOI: 10.1177/1078155213494940  0.8
2014 Sotnikov I, Veremeyko T, Starossom SC, Barteneva N, Weiner HL, Ponomarev ED. Correction: Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation Plos One. 9. DOI: 10.1371/annotation/0bbea8d3-1f94-48af-915c-aec02da2f5c3  0.8
2014 Quintana FJ, Patel B, Yeste A, Nyirenda M, Kenison J, Rahbari R, Fetco D, Hussain M, O'Mahony J, Magalhaes S, McGowan M, Johnson T, Rajasekharan S, Narayanan S, Arnold DL, ... Weiner HL, et al. Epitope spreading as an early pathogenic event in pediatric multiple sclerosis Neurology. 83: 2219-2226.  0.8
2013 Shekhtman Y, Kim I, Riviello JJ, Milla SS, Weiner HL. Focal resection of leptomeningeal angioma in a rare case of Sturge-Weber syndrome without facial nevus. Pediatric Neurosurgery. 49: 99-104. PMID 24434861 DOI: 10.1159/000357357  0.8
2013 Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, Shaw SY, Ananthakrishnan AN, Szolovits P, Weiner HL, Karlson EW, et al. Modeling disease severity in multiple sclerosis using electronic health records. Plos One. 8: e78927. PMID 24244385 DOI: 10.1371/journal.pone.0078927  0.8
2013 Messina S, Vargas-Lowy D, Musallam A, Healy BC, Kivisakk P, Gandhi R, Bove R, Gholipour T, Khoury S, Weiner HL, Chitnis T. Increased leptin and A-FABP levels in relapsing and progressive forms of MS. Bmc Neurology. 13: 172. PMID 24215402 DOI: 10.1186/1471-2377-13-172  0.8
2013 Ottoboni L, Frohlich IY, Lee M, Healy BC, Keenan BT, Xia Z, Chitnis T, Guttmann CR, Khoury SJ, Weiner HL, Hafler DA, De Jager PL. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology. 81: 1891-9. PMID 24174586 DOI: 10.1212/01.wnl.0000436612.66328.8a  0.8
2013 Roth J, Roach ES, Bartels U, Jóźwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatric Neurology. 49: 439-44. PMID 24138953 DOI: 10.1016/j.pediatrneurol.2013.08.017  0.8
2013 Frenkel D, Wilkinson K, Zhao L, Hickman SE, Means TK, Puckett L, Farfara D, Kingery ND, Weiner HL, El Khoury J. Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression. Nature Communications. 4: 2030. PMID 23799536 DOI: 10.1038/ncomms3030  0.8
2013 Hersh DS, Chun J, Weiner HL, Pulitzer S, Rusinek H, Roth J, Devinsky O, Milla SS. Longitudinal quantitative analysis of the tuber-to-brain proportion in patients with tuberous sclerosis. Journal of Neurosurgery. Pediatrics. 12: 71-6. PMID 23662930 DOI: 10.3171/2013.4.PEDS12468  0.8
2013 Sotnikov I, Veremeyko T, Starossom SC, Barteneva N, Weiner HL, Ponomarev ED. Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation. Plos One. 8: e58979. PMID 23555611 DOI: 10.1371/journal.pone.0058979  0.8
2013 Koeglsperger T, Li S, Brenneis C, Saulnier JL, Mayo L, Carrier Y, Selkoe DJ, Weiner HL. Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-β1 in the CNS. Glia. 61: 985-1002. PMID 23536313 DOI: 10.1002/glia.22490  0.8
2013 Bove R, Secor E, Healy BC, Musallam A, Vaughan T, Glanz BI, Greeke E, Weiner HL, Chitnis T, Wicks P, De Jager PL. Evaluation of an online platform for multiple sclerosis research: patient description, validation of severity scale, and exploration of BMI effects on disease course. Plos One. 8: e59707. PMID 23527256 DOI: 10.1371/journal.pone.0059707  0.8
2013 Hu D, Weiner HL, Ritz J. Identification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral blood. Plos One. 8: e59545. PMID 23527216 DOI: 10.1371/journal.pone.0059545  0.8
2013 Wu WE, Kirov II, Tal A, Babb JS, Milla S, Oved J, Weiner HL, Devinsky O, Gonen O. Brain MR spectroscopic abnormalities in "MRI-negative" tuberous sclerosis complex patients. Epilepsy & Behavior : E&B. 27: 319-25. PMID 23524469 DOI: 10.1016/j.yebeh.2013.02.018  0.8
2013 Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Annals of Neurology. 73: 729-40. PMID 23494648 DOI: 10.1002/ana.23880  0.8
2013 Chalifoux JR, Perry N, Katz JS, Wiggins GC, Roth J, Miles D, Devinsky O, Weiner HL, Milla SS. The ability of high field strength 7-T magnetic resonance imaging to reveal previously uncharacterized brain lesions in patients with tuberous sclerosis complex. Journal of Neurosurgery. Pediatrics. 11: 268-73. PMID 23289918 DOI: 10.3171/2012.12.PEDS12338  0.8
2013 Stankiewicz JM, Kolb H, Karni A, Weiner HL. Role of immunosuppressive therapy for the treatment of multiple sclerosis. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 77-88. PMID 23271506 DOI: 10.1007/s13311-012-0172-3  0.8
2013 Vaughn J, Hagiwara M, Katz J, Roth J, Devinsky O, Weiner H, Milla S. MRI characterization and longitudinal study of focal cerebellar lesions in a young tuberous sclerosis cohort. Ajnr. American Journal of Neuroradiology. 34: 655-9. PMID 22954744 DOI: 10.3174/ajnr.A3260  0.8
2013 Rezende RM, Oliveira RP, Medeiros SR, Gomes-Santos AC, Alves AC, Loli FG, Guimarães MA, Amaral SS, da Cunha AP, Weiner HL, Azevedo V, Miyoshi A, Faria AM. Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells. Journal of Autoimmunity. 40: 45-57. PMID 22939403 DOI: 10.1016/j.jaut.2012.07.012  0.8
2013 Ponomarev ED, Veremeyko T, Weiner HL. MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia. 61: 91-103. PMID 22653784 DOI: 10.1002/glia.22363  0.8
2013 Quintana FJ, Weiner HL. Multiple Sclerosis Genomic and Personalized Medicine. 2: 853-862. DOI: 10.1016/B978-0-12-382227-7.00072-0  0.8
2012 Glanz BI, Dégano IR, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 1029-35. PMID 23244804 DOI: 10.1016/j.jval.2012.07.010  0.8
2012 Murugaiyan G, Beynon V, Pires Da Cunha A, Joller N, Weiner HL. IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27. Journal of Immunology (Baltimore, Md. : 1950). 189: 5277-83. PMID 23125412 DOI: 10.4049/jimmunol.1200808  0.8
2012 Chen L, Chen Z, Baker K, Halvorsen EM, da Cunha AP, Flak MB, Gerber G, Huang YH, Hosomi S, Arthur JC, Dery KJ, Nagaishi T, Beauchemin N, Holmes KV, Ho JW, ... ... Weiner HL, et al. The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction. Immunity. 37: 930-46. PMID 23123061 DOI: 10.1016/j.immuni.2012.07.016  0.8
2012 Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, et al. Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial. Lancet (London, England). 380: 1819-28. PMID 23122652 DOI: 10.1016/S0140-6736(12)61769-3  0.8
2012 Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, et al. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet (London, England). 380: 1829-39. PMID 23122650 DOI: 10.1016/S0140-6736(12)61768-1  0.8
2012 Ottoboni L, Keenan BT, Tamayo P, Kuchroo M, Mesirov JP, Buckle GJ, Khoury SJ, Hafler DA, Weiner HL, De Jager PL. An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity. Science Translational Medicine. 4: 153ra131. PMID 23019656 DOI: 10.1126/scitranslmed.3004186  0.8
2012 Ma TS, Elliott RE, Ruppe V, Devinsky O, Kuzniecky R, Weiner HL, Carlson C. Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex. Journal of Neurosurgery. Pediatrics. 10: 376-82. PMID 22998031 DOI: 10.3171/2012.8.PEDS1285  0.8
2012 Veremeyko T, Starossom SC, Weiner HL, Ponomarev ED. Detection of microRNAs in microglia by real-time PCR in normal CNS and during neuroinflammation. Journal of Visualized Experiments : Jove. PMID 22872097 DOI: 10.3791/4097  0.8
2012 Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. The Journal of Clinical Investigation. 122: 3063-87. PMID 22863620 DOI: 10.1172/JCI62636  0.8
2012 Weiner HL. Role of T cells in neuromyelitis optica. Annals of Neurology. 72: 6-8. PMID 22829264 DOI: 10.1002/ana.23669  0.8
2012 Beynon V, Quintana FJ, Weiner HL. Activated human CD4+CD45RO+ memory T-cells indirectly inhibit NLRP3 inflammasome activation through downregulation of P2X7R signalling. Plos One. 7: e39576. PMID 22768094 DOI: 10.1371/journal.pone.0039576  0.8
2012 Yeste A, Nadeau M, Burns EJ, Weiner HL, Quintana FJ. Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 109: 11270-5. PMID 22745170 DOI: 10.1073/pnas.1120611109  0.8
2012 Mayo L, Quintana FJ, Weiner HL. The innate immune system in demyelinating disease. Immunological Reviews. 248: 170-87. PMID 22725961 DOI: 10.1111/j.1600-065X.2012.01135.x  0.8
2012 Quintana FJ, Yeste A, Weiner HL, Covacu R. Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis. Journal of Neuroimmunology. 248: 53-7. PMID 22579051 DOI: 10.1016/j.jneuroim.2012.01.002  0.8
2012 Rodgers SD, Bassani L, Weiner HL, Harter DH. Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma: case report. Journal of Neurosurgery. Pediatrics. 9: 417-20. PMID 22462708 DOI: 10.3171/2011.12.PEDS11349  0.8
2012 Katz JS, Milla SS, Wiggins GC, Devinsky O, Weiner HL, Roth J. Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus. Journal of Neurosurgery. Pediatrics. 9: 406-13. PMID 22462706 DOI: 10.3171/2011.12.PEDS11418  0.8
2012 Ceccarelli A, Jackson JS, Tauhid S, Arora A, Gorky J, Dell'Oglio E, Bakshi A, Chitnis T, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R, Neema M. The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 33: 1579-85. PMID 22460341 DOI: 10.3174/ajnr.A3083  0.8
2012 Mittal A, Murugaiyan G, Beynon V, Hu D, Weiner HL. IL-27 induction of IL-21 from human CD8+ T cells induces granzyme B in an autocrine manner. Immunology and Cell Biology. 90: 831-5. PMID 22430249 DOI: 10.1038/icb.2012.14  0.8
2012 Quintana FJ, Farez MF, Izquierdo G, Lucas M, Cohen IR, Weiner HL. Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology. 78: 532-9. PMID 22262743 DOI: 10.1212/WNL.0b013e318247f9f3  0.8
2012 Roth J, Olasunkanmi A, Ma TS, Carlson C, Devinsky O, Harter DH, Weiner HL. Epilepsy control following intracranial monitoring without resection in young children. Epilepsia. 53: 334-41. PMID 22242686 DOI: 10.1111/j.1528-1167.2011.03380.x  0.8
2012 Healy BC, Degano IR, Schreck A, Rintell D, Weiner H, Chitnis T, Glanz BI. The impact of a recent relapse on patient-reported outcomes in subjects with multiple sclerosis. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation. 21: 1677-84. PMID 22237991 DOI: 10.1007/s11136-011-0108-0  0.8
2012 Moodie J, Healy BC, Buckle GJ, Gauthier SA, Glanz BI, Arora A, Ceccarelli A, Tauhid S, Han XM, Venkataraman A, Chitnis T, Khoury SJ, Guttmann CR, Weiner HL, Neema M, et al. Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study. Journal of the Neurological Sciences. 315: 49-54. PMID 22209496 DOI: 10.1016/j.jns.2011.11.040  0.8
2012 da Cunha AP, Weiner HL. Induction of immunological tolerance by oral anti-CD3. Clinical & Developmental Immunology. 2012: 425021. PMID 22162715 DOI: 10.1155/2012/425021  0.8
2012 Hu D, Liu X, Zeng W, Weiner HL, Ritz J. A clonal model for human CD8+ regulatory T cells: unrestricted contact-dependent killing of activated CD4+ T cells. European Journal of Immunology. 42: 69-79. PMID 22002875 DOI: 10.1002/eji.201141618  0.8
2012 Glanz BI, Healy BC, Hviid LE, Chitnis T, Weiner HL. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 38-43. PMID 21746743 DOI: 10.1136/jnnp.2010.237834  0.8
2012 Holland CM, Charil A, Csapo I, Liptak Z, Ichise M, Khoury SJ, Bakshi R, Weiner HL, Guttmann CR. The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 22: 129-36. PMID 21447022 DOI: 10.1111/j.1552-6569.2011.00585.x  0.8
2012 Lifshitz V, Weiss R, Benromano T, Kfir E, Blumenfeld-Katzir T, Tempel-Brami C, Assaf Y, Xia W, Wyss-Coray T, Weiner HL, Frenkel D. Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model. Neurobiology of Aging. 33: 432.e1-432.e13. PMID 21371785 DOI: 10.1016/j.neurobiolaging.2011.01.006  0.8
2012 Weiner HL, Edwards L. Future Therapeutic Approaches Multiple Sclerosis: Diagnosis and Therapy. 283-300. DOI: 10.1002/9781119963714.ch12  0.8
2012 Gandhi R, Weiner HL. Disease Pathogenesis Multiple Sclerosis: Diagnosis and Therapy. 1-25. DOI: 10.1002/9781119963714.ch1  0.8
2012 Weiner HL, Stankiewicz JM. Multiple Sclerosis: Diagnosis and Therapy Multiple Sclerosis: Diagnosis and Therapy. DOI: 10.1002/9781119963714  0.8
2011 Laroni A, Gandhi R, Beynon V, Weiner HL. IL-27 imparts immunoregulatory function to human NK cell subsets. Plos One. 6: e26173. PMID 22039443 DOI: 10.1371/journal.pone.0026173  0.8
2011 Cassani B, Villablanca EJ, Quintana FJ, Love PE, Lacy-Hulbert A, Blaner WS, Sparwasser T, Snapper SB, Weiner HL, Mora JR. Gut-tropic T cells that express integrin α4β7 and CCR9 are required for induction of oral immune tolerance in mice. Gastroenterology. 141: 2109-18. PMID 21925467 DOI: 10.1053/j.gastro.2011.09.015  0.8
2011 Wu HY, Quintana FJ, da Cunha AP, Dake BT, Koeglsperger T, Starossom SC, Weiner HL. In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. Plos One. 6: e23618. PMID 21886804 DOI: 10.1371/journal.pone.0023618  0.8
2011 Murugaiyan G, Beynon V, Mittal A, Joller N, Weiner HL. Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 187: 2213-21. PMID 21788439 DOI: 10.4049/jimmunol.1003952  0.8
2011 Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, ... ... Weiner HL, et al. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. The Lancet. Neurology. 10: 745-58. PMID 21777829 DOI: 10.1016/S1474-4422(11)70149-1  0.8
2011 Santiago AF, Alves AC, Oliveira RP, Fernandes RM, Paula-Silva J, Assis FA, Carvalho CR, Weiner HL, Faria AM. Aging correlates with reduction in regulatory-type cytokines and T cells in the gut mucosa. Immunobiology. 216: 1085-93. PMID 21676485 DOI: 10.1016/j.imbio.2011.05.007  0.8
2011 Sansa G, Carlson C, Doyle W, Weiner HL, Bluvstein J, Barr W, Devinsky O. Medically refractory epilepsy in autism. Epilepsia. 52: 1071-5. PMID 21671922 DOI: 10.1111/j.1528-1167.2011.03069.x  0.8
2011 Gholipour T, Healy B, Baruch NF, Weiner HL, Chitnis T. Demographic and clinical characteristics of malignant multiple sclerosis. Neurology. 76: 1996-2001. PMID 21646626 DOI: 10.1212/WNL.0b013e31821e559d  0.8
2011 Pacione D, Blei F, Devinsky O, Weiner HL, Roth J. Coagulation abnormalities in children undergoing epilepsy surgery. Journal of Neurosurgery. Pediatrics. 7: 654-9. PMID 21631205 DOI: 10.3171/2011.3.PEDS10559  0.8
2011 Oida T, Weiner HL. Murine CD4 T cells produce a new form of TGF-β as measured by a newly developed TGF-β bioassay. Plos One. 6: e18365. PMID 21494571 DOI: 10.1371/journal.pone.0018365  0.8
2011 Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunological Reviews. 241: 241-59. PMID 21488901 DOI: 10.1111/j.1600-065X.2011.01017.x  0.8
2011 Carlson C, Teutonico F, Elliott RE, Moshel YA, LaJoie J, Miles D, Devinsky O, Weiner HL. Bilateral invasive electroencephalography in patients with tuberous sclerosis complex: a path to surgery? Journal of Neurosurgery. Pediatrics. 7: 421-30. PMID 21456917 DOI: 10.3171/2011.1.PEDS10348  0.8
2011 Liguori M, Meier DS, Hildenbrand P, Healy BC, Chitnis T, Baruch NF, Khoury SJ, Weiner HL, Bakshi R, Barkhof F, Guttmann CR. One year activity on subtraction MRI predicts subsequent 4 year activity and progression in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 1125-31. PMID 21429902 DOI: 10.1136/jnnp.2011.242115  0.8
2011 Hviid LE, Healy BC, Rintell DJ, Chitnis T, Weiner HL, Glanz BI. Patient reported outcomes in benign multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 876-84. PMID 21372114 DOI: 10.1177/1352458511398370  0.8
2011 Roth J, Olasunkanmi A, MacAllister WS, Weil E, Uy CC, Devinsky O, Weiner HL. Quality of life following epilepsy surgery for children with tuberous sclerosis complex. Epilepsy & Behavior : E&B. 20: 561-5. PMID 21288778 DOI: 10.1016/j.yebeh.2010.11.003  0.8
2011 Healy BC, Engler D, Gholipour T, Weiner H, Bakshi R, Chitnis T. Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis. Journal of the Neurological Sciences. 303: 109-13. PMID 21251671 DOI: 10.1016/j.jns.2010.12.024  0.8
2011 Liguori M, Healy BC, Glanz BI, Khoury SJ, Moscufo N, Weiner HL, De Jager PL, Guttmann CR. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study. Genes and Immunity. 12: 183-90. PMID 21179117 DOI: 10.1038/gene.2010.58  0.8
2011 Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nature Medicine. 17: 64-70. PMID 21131957 DOI: 10.1038/nm.2266  0.8
2011 Gross R, Healy BC, Cepok S, Chitnis T, Khoury SJ, Hemmer B, Weiner HL, Hafler DA, De Jager PL. Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatments. Journal of Neuroimmunology. 233: 168-74. PMID 21115201 DOI: 10.1016/j.jneuroim.2010.10.038  0.8
2011 Roth J, Galeano E, Milla S, Hartmannsgruber MW, Weiner HL. Multiple epidural hematomas and hemodynamic collapse caused by a subgaleal drain and suction-induced intracranial hypotension: case report. Neurosurgery. 68: E271-5; discussion E. PMID 21099705 DOI: 10.1227/NEU.0b013e3181fe6165  0.8
2011 Haranhalli N, Anand D, Wisoff JH, Harter DH, Weiner HL, Blate M, Roth J. Intrathecal baclofen therapy: complication avoidance and management. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 27: 421-7. PMID 20853002 DOI: 10.1007/s00381-010-1277-9  0.8
2011 Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RH, Guss ZD, Tauhid S, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R. Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 21: e50-6. PMID 19888926 DOI: 10.1111/j.1552-6569.2009.00449.x  0.8
2011 Farez MF, Gandhi R, Quintana F, Weiner HL. Reply to-Detecting oxysterols in the human circulation Nature Immunology. 12: 577-578. DOI: 10.1038/ni0711-577b  0.8
2011 Stankiewicz JM, Weiner HL. Use of immunosuppressants to treat multiple sclerosis Multiple Sclerosis Therapeutics, Fourth Edition. 436-443. DOI: 10.1017/CBO9781139023986.040  0.8
2011 Weiner HL. Multiple sclerosis: The next 20 years Current Clinical Neurology. 40: 191-200. DOI: 10.1007/978-1-60327-860-7_10  0.8
2010 Xia Z, Chibnik LB, Glanz BI, Liguori M, Shulman JM, Tran D, Khoury SJ, Chitnis T, Holyoak T, Weiner HL, Guttmann CR, De Jager PL. A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis. Plos One. 5: e14169. PMID 21152065 DOI: 10.1371/journal.pone.0014169  0.8
2010 Oida T, Weiner HL. TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction. Plos One. 5: e15523. PMID 21124798 DOI: 10.1371/journal.pone.0015523  0.8
2010 Quintana FJ, Murugaiyan G, Farez MF, Mitsdoerffer M, Tukpah AM, Burns EJ, Weiner HL. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 107: 20768-73. PMID 21068375 DOI: 10.1073/pnas.1009201107  0.8
2010 Balashov KE, Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, Weiner HL. Interferon-β inhibits toll-like receptor 9 processing in multiple sclerosis. Annals of Neurology. 68: 899-906. PMID 21061396 DOI: 10.1002/ana.22136  0.8
2010 Vega JL, Saban D, Carrier Y, Masli S, Weiner HL. Retinal pigment epithelial cells induce foxp3(+) regulatory T cells via membrane-bound TGF-β. Ocular Immunology and Inflammation. 18: 459-69. PMID 20887202 DOI: 10.3109/09273948.2010.509532  0.8
2010 Khoury SJ, Healy BC, Kivisäkk P, Viglietta V, Egorova S, Guttmann CR, Wedgwood JF, Hafler DA, Weiner HL, Buckle G, Cook S, Reddy S. A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis. Archives of Neurology. 67: 1055-61. PMID 20837847 DOI: 10.1001/archneurol.2010.222  0.8
2010 Oida T, Weiner HL. Depletion of TGF-β from fetal bovine serum. Journal of Immunological Methods. 362: 195-8. PMID 20837018 DOI: 10.1016/j.jim.2010.09.008  0.8
2010 Meier DS, Balashov KE, Healy B, Weiner HL, Guttmann CR. Seasonal prevalence of MS disease activity. Neurology. 75: 799-806. PMID 20805526 DOI: 10.1212/WNL.0b013e3181f0734c  0.8
2010 Oida T, Weiner HL. Overexpression of TGF-ß 1 gene induces cell surface localized glucose-regulated protein 78-associated latency-associated peptide/TGF-ß. Journal of Immunology (Baltimore, Md. : 1950). 185: 3529-35. PMID 20720212 DOI: 10.4049/jimmunol.0904121  0.8
2010 Wu HY, Maron R, Tukpah AM, Weiner HL. Mucosal anti-CD3 monoclonal antibody attenuates collagen-induced arthritis that is associated with induction of LAP+ regulatory T cells and is enhanced by administration of an emulsome-based Th2-skewing adjuvant. Journal of Immunology (Baltimore, Md. : 1950). 185: 3401-7. PMID 20720210 DOI: 10.4049/jimmunol.1000836  0.8
2010 Healy BC, Liguori M, Tran D, Chitnis T, Glanz B, Wolfish C, Gauthier S, Buckle G, Houtchens M, Stazzone L, Khoury S, Hartzmann R, Fernandez-Vina M, Hafler DA, Weiner HL, et al. HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology. 75: 634-40. PMID 20713950 DOI: 10.1212/WNL.0b013e3181ed9c9c  0.8
2010 Apetoh L, Quintana FJ, Pot C, Joller N, Xiao S, Kumar D, Burns EJ, Sherr DH, Weiner HL, Kuchroo VK. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nature Immunology. 11: 854-61. PMID 20676095 DOI: 10.1038/ni.1912  0.8
2010 Gandhi R, Kumar D, Burns EJ, Nadeau M, Dake B, Laroni A, Kozoriz D, Weiner HL, Quintana FJ. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nature Immunology. 11: 846-53. PMID 20676092 DOI: 10.1038/ni.1915  0.8
2010 Souweidane MM, Krieger MD, Weiner HL, Finlay JL. Surgical management of primary central nervous system germ cell tumors: proceedings from the Second International Symposium on Central Nervous System Germ Cell Tumors. Journal of Neurosurgery. Pediatrics. 6: 125-30. PMID 20672932 DOI: 10.3171/2010.5.PEDS09112  0.8
2010 Peron JP, Yang K, Chen ML, Brandao WN, Basso AS, Commodaro AG, Weiner HL, Rizzo LV. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. Journal of Neuroimmunology. 227: 10-7. PMID 20580440 DOI: 10.1016/j.jneuroim.2010.06.002  0.8
2010 Murugaiyan G, Mittal A, Weiner HL. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-γ limits IL-17-mediated autoimmune inflammation Proceedings of the National Academy of Sciences of the United States of America. 107: 11495-11500. PMID 20534530 DOI: 10.1073/pnas.1002099107  0.8
2010 Moshel YA, Elliott R, Teutonico F, Sellin J, Carlson C, Devinsky O, Weiner HL. Do tubers contain function? Resection of epileptogenic foci in perirolandic cortex in children with tuberous sclerosis complex Epilepsia. 51: 1242-1251. PMID 20491878 DOI: 10.1111/j.1528-1167.2009.02493.x  0.8
2010 Ilan Y, Maron R, Tukpah AM, Maioli TU, Murugaiyan G, Yang K, Wu HY, Weiner HL. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice Proceedings of the National Academy of Sciences of the United States of America. 107: 9765-9770. PMID 20445103 DOI: 10.1073/pnas.0908771107  0.8
2010 Rodriguez-Manzanet R, Sanjuan MA, Wu HY, Quintana FJ, Xiao S, Anderson AC, Weiner HL, Green DR, Kuchroo VK. T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proceedings of the National Academy of Sciences of the United States of America. 107: 8706-11. PMID 20368430 DOI: 10.1073/pnas.0910359107  0.8
2010 Gandhi R, Farez MF, Wang Y, Kozoriz D, Quintana FJ, Weiner HL. Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset. Journal of Immunology (Baltimore, Md. : 1950). 184: 4620-4. PMID 20368276 DOI: 10.4049/jimmunol.0903329  0.8
2010 Quintana FJ, Iglesias AH, Farez MF, Caccamo M, Burns EJ, Kassam N, Oukka M, Weiner HL. Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish Plos One. 5. PMID 20221429 DOI: 10.1371/journal.pone.0009478  0.8
2010 Glanz BI, Healy BC, Rintell DJ, Jaffin SK, Bakshi R, Weiner HL. The association between cognitive impairment and quality of life in patients with early multiple sclerosis. Journal of the Neurological Sciences. 290: 75-9. PMID 19944429 DOI: 10.1016/j.jns.2009.11.004  0.8
2010 Gandhi R, Laroni A, Weiner HL. Role of the innate immune system in the pathogenesis of multiple sclerosis. Journal of Neuroimmunology. 221: 7-14. PMID 19931190 DOI: 10.1016/j.jneuroim.2009.10.015  0.8
2010 Ilan Y, Zigmond E, Lalazar G, Dembinsky A, Ben Ya'acov A, Hemed N, Kasis I, Axelrod E, Zolotarov L, Klein A, El Haj M, Gandhi R, Baecher-Allan C, Wu H, Murugaiyan G, ... ... Weiner HL, et al. Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells. Journal of Clinical Immunology. 30: 167-77. PMID 19756989 DOI: 10.1007/s10875-009-9323-7  0.8
2010 Souweidane MM, Krieger MD, Weiner HL, Finlay JL. Response Journal of Neurosurgery: Pediatrics. 6: 124. DOI: 10.3171/2009.12.PEDS09480  0.8
2010 Quintana FJ, Weiner HL. Genomic Evaluation of Multiple Sclerosis Essentials of Genomic and Personalized Medicine. 566-574. DOI: 10.1016/B978-0-12-374934-5.00044-1  0.8
2010 Thiele EA, Weiner HL. Epilepsy in TSC Tuberous Sclerosis Complex: Genes, Clinical Features and Therapeutics. 187-210. DOI: 10.1002/9783527630073.ch10  0.8
2010 Elkhalifa AS, Weiner HL. Cyclophosphamide treatment of MS: Current therapeutic approaches and treatment regimens International Ms Journal. 17: 12-18.  0.8
2009 Chen ML, Yan BS, Kozoriz D, Weiner HL. Novel CD8+ Treg suppress EAE by TGF-β- and IFN-γ-dependent mechanisms European Journal of Immunology. 39: 3423-3435. PMID 19768696 DOI: 10.1002/eji.200939441  0.8
2009 Elliott RE, Carlson C, Kalhorn SP, Moshel YA, Weiner HL, Devinsky O, Doyle WK. Refractory epilepsy in tuberous sclerosis: Vagus nerve stimulation with or without subsequent resective surgery Epilepsy and Behavior. 16: 454-460. PMID 19767244 DOI: 10.1016/j.yebeh.2009.08.018  0.8
2009 Sampat MP, Berger AM, Healy BC, Hildenbrand P, Vass J, Meier DS, Chitnis T, Weiner HL, Bakshi R, Guttmann CR. Regional white matter atrophy--based classification of multiple sclerosis in cross-sectional and longitudinal data. Ajnr. American Journal of Neuroradiology. 30: 1731-9. PMID 19696139 DOI: 10.3174/ajnr.A1659  0.8
2009 Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M, Weiner HL. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nature Immunology. 10: 958-64. PMID 19684606 DOI: 10.1038/ni.1775  0.8
2009 Zota V, Nemirovsky A, Baron R, Fisher Y, Selkoe DJ, Altmann DM, Weiner HL, Monsonego A. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele. Journal of Immunology (Baltimore, Md. : 1950). 183: 3522-30. PMID 19675171 DOI: 10.4049/jimmunol.0900620  0.8
2009 Murugaiyan G, Mittal A, Lopez-Diego R, Maier LM, Anderson DE, Weiner HL. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 183: 2435-43. PMID 19625647 DOI: 10.4049/jimmunol.0900568  0.8
2009 Bollo RJ, Berliner JL, Fischer I, Miles DK, Thiele EA, Zagzag D, Weiner HL. Extraventricular subependymal giant cell tumor in a child with tuberous sclerosis complex. Journal of Neurosurgery. Pediatrics. 4: 85-90. PMID 19569916 DOI: 10.3171/2009.3.PEDS08225  0.8
2009 De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, Baranzini SE, McCauley JL, ... ... Weiner HL, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature Genetics. 41: 776-82. PMID 19525953 DOI: 10.1038/ng.401  0.8
2009 Frenkel D, Pachori AS, Zhang L, Dembinsky-Vaknin A, Farfara D, Petrovic-Stojkovic S, Dzau VJ, Weiner HL. Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury. International Immunology. 21: 817-29. PMID 19515797 DOI: 10.1093/intimm/dxp051  0.8
2009 Kivisäkk P, Healy BC, Viglietta V, Quintana FJ, Hootstein MA, Weiner HL, Khoury SJ. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology. 72: 1922-30. PMID 19487650 DOI: 10.1212/WNL.0b013e3181a8266f  0.8
2009 Bollo RJ, Carlson C, Schevon C, Wisoff JH, Devinsky O, Weiner HL. Extraoperative functional mapping and staged resection of supratentorial tumors near eloquent cortex in children Pediatric Neurosurgery. 45: 175-180. PMID 19440004 DOI: 10.1159/000218199  0.8
2009 Wu HY, Center EM, Tsokos GC, Weiner HL. Suppression of murine SLE by oral anti-CD3: Inducible CD4+CD25-LAP+ regulatory T cells control the expansion of IL-17+ follicular helper T cells Lupus. 18: 586-596. PMID 19433458 DOI: 10.1177/0961203308100511  0.8
2009 Gauthier SA, Glanz BI, Mandel M, Tsagkaropoulos A, Neema M, Stankiewicz J, Arora A, Duan Y, Liptak Z, Egorova S, Buckle GJ, Bakshi R, Guttmann CR, Khoury SJ, Weiner HL. Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study. Journal of the Neurological Sciences. 284: 116-9. PMID 19428028 DOI: 10.1016/j.jns.2009.04.020  0.8
2009 Weiner HL. The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease? Annals of Neurology. 65: 239-248. PMID 19334069 DOI: 10.1002/ana.21640  0.8
2009 Quinatana FJ, Weiner HL. Environmental control of Th17 differentiation European Journal of Immunology. 39: 655-657. PMID 19283716 DOI: 10.1002/eji.200839198  0.8
2009 Neema M, Goldberg-Zimring D, Guss ZD, Healy BC, Guttmann CR, Houtchens MK, Weiner HL, Horsfield MA, Hackney DB, Alsop DC, Bakshi R. 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. Neuroimage. 46: 633-41. PMID 19281850 DOI: 10.1016/j.neuroimage.2009.03.001  0.8
2009 De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, ... ... Weiner HL, et al. The role of the CD58 locus in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 106: 5264-9. PMID 19237575 DOI: 10.1073/pnas.0813310106  0.8
2009 Gauthier SA, Berger AM, Liptak Z, Duan Y, Egorova S, Buckle GJ, Glanz BI, Khoury SJ, Bakshi R, Weiner HL, Guttmann CR. Rate of brain atrophy in benign vs early multiple sclerosis. Archives of Neurology. 66: 234-7. PMID 19204160 DOI: 10.1001/archneurol.2008.567  0.8
2009 Neema M, Arora A, Healy BC, Guss ZD, Brass SD, Duan Y, Buckle GJ, Glanz BI, Stazzone L, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. 19: 3-8. PMID 19192042 DOI: 10.1111/j.1552-6569.2008.00296.x  0.8
2009 Yang K, Vega JL, Hadzipasic M, Schatzmann Peron JP, Zhu B, Carrier Y, Masli S, Rizzo LV, Weiner HL. Deficiency of thrombospondin-1 reduces Th17 differentiation and attenuates experimental autoimmune encephalomyelitis. Journal of Autoimmunity. 32: 94-103. PMID 19181483 DOI: 10.1016/j.jaut.2008.12.004  0.8
2009 Ali EN, Healy BC, Stazzone LA, Brown BA, Weiner HL, Khoury SJ. Daclizumab in treatment of multiple sclerosis patients. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 272-4. PMID 19136546 DOI: 10.1177/1352458508097468  0.8
2009 Quintana FJ, Weiner HL. "Omics" in the Study of Multiple Sclerosis Genomic and Personalized Medicine, Two-Vol Set. 1032-1039. DOI: 10.1016/B978-0-12-369420-1.00085-8  0.8
2009 Murugaiyan G, Mittal A, Weiner HL. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis Journal of Immunology. 181: 7480-7488.  0.8
2008 Quintana FJ, Farez MF, Viglietta V, Iglesias AH, Merbl Y, Izquierdo G, Lucas M, Basso AS, Khoury SJ, Lucchinetti CF, Cohen IR, Weiner HL. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 105: 18889-94. PMID 19028871 DOI: 10.1073/pnas.0806310105  0.8
2008 Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, ... Weiner HL, et al. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Archives of Neurology. 65: 1449-53. PMID 19001162 DOI: 10.1001/archneur.65.11.1449  0.8
2008 Lopez-Diego RS, Weiner HL. Novel therapeutic strategies for multiple sclerosis - A multifaceted adversary Nature Reviews Drug Discovery. 7: 909-925. PMID 18974749 DOI: 10.1038/nrd2358  0.8
2008 Wu HY, Quintana FJ, Weiner HL. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+CD25-LAP+ regulatory T Cell and is associated with down-regulation of IL-17+CD4+ICOS +CXCR5+ follicular helper T cells Journal of Immunology. 181: 6038-6050. PMID 18941193  0.8
2008 Ochi H, Abraham M, Ishikawa H, Frenkel D, Yang K, Basso A, Wu H, Chen ML, Gandhi R, Miller A, Maron R, Weiner HL. New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity. Journal of the Neurological Sciences. 274: 9-12. PMID 18804221 DOI: 10.1016/j.jns.2008.07.027  0.8
2008 Viglietta V, Bourcier K, Buckle GJ, Healy B, Weiner HL, Hafler DA, Egorova S, Guttmann CR, Rusche JR, Khoury SJ. CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial. Neurology. 71: 917-24. PMID 18794494 DOI: 10.1212/01.wnl.0000325915.00112.61  0.8
2008 Bollo RJ, Kalhorn SP, Carlson C, Haegeli V, Devinsky O, Weiner HL. Epilepsy surgery and tuberous sclerosis complex: Special considerations: A review Neurosurgical Focus. 25. PMID 18759614 DOI: 10.3171/FOC/2008/25/9/E13  0.8
2008 Teutonico F, Mai R, Devinsky O, Lo Russo G, Weiner HL, Borrelli P, Balottin U, Veggiotti P. Epilepsy surgery in tuberous sclerosis complex: Early predictive elements and outcome Child's Nervous System. 24: 1437-1445. PMID 18704447 DOI: 10.1007/s00381-008-0679-4  0.8
2008 Weiner HL. Oral laquinimod for treatment of relapsing-remitting multiple sclerosis The Lancet Neurology. 7: 672-673. PMID 18635014 DOI: 10.1016/S1474-4422(08)70148-0  0.8
2008 Fischer I, Cunliffe C, Bollo RJ, Weiner HL, Devinsky O, Ruiz-Tachiquin ME, Venuto T, Pearlman A, Chiriboga L, Schneider RJ, Ostrer H, Miller DC. Glioma-like proliferation within tissues excised as tubers in patients with tuberous sclerosis complex. Acta Neuropathologica. 116: 67-77. PMID 18581125 DOI: 10.1007/s00401-008-0391-1  0.8
2008 De Jager PL, Rossin E, Pyne S, Tamayo P, Ottoboni L, Viglietta V, Weiner M, Soler D, Izmailova E, Faron-Yowe L, O'Brien C, Freeman S, Granados S, Parker A, Roubenoff R, ... ... Weiner HL, et al. Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells. Brain : a Journal of Neurology. 131: 1701-11. PMID 18567923 DOI: 10.1093/brain/awn118  0.8
2008 Liptak Z, Berger AM, Sampat MP, Charil A, Felsovalyi O, Healy BC, Hildenbrand P, Khoury SJ, Weiner HL, Bakshi R, Guttmann CR. Medulla oblongata volume: a biomarker of spinal cord damage and disability in multiple sclerosis. Ajnr. American Journal of Neuroradiology. 29: 1465-70. PMID 18556361 DOI: 10.3174/ajnr.A1162  0.8
2008 Quintana FJ, Farez MF, Weiner HL. Systems biology approaches for the study of multiple sclerosis Journal of Cellular and Molecular Medicine. 12: 1087-1093. PMID 18505469 DOI: 10.1111/j.1582-4934.2008.00375.x  0.8
2008 Chen ML, Yan BS, Bando Y, Kuchroo VK, Weiner HL. Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis. Journal of Immunology (Baltimore, Md. : 1950). 180: 7327-37. PMID 18490732  0.8
2008 Vaknin-Dembinsky A, Murugaiyan G, Hafler DA, Astier AL, Weiner HL. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. Journal of Neuroimmunology. 195: 140-5. PMID 18403025 DOI: 10.1016/j.jneuroim.2008.01.002  0.8
2008 Vaknin-Dembinsky A, Brass SD, Brass S, Gandhi R, Weiner HL. Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS. Journal of Neuroimmunology. 195: 135-9. PMID 18378324 DOI: 10.1016/j.jneuroim.2008.01.016  0.8
2008 Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 453: 65-71. PMID 18362915 DOI: 10.1038/nature06880  0.8
2008 Frenkel D, Puckett L, Petrovic S, Xia W, Chen G, Vega J, Dembinsky-Vaknin A, Shen J, Plante M, Burt DS, Weiner HL. A nasal proteosome adjuvant activates microglia and prevents amyloid deposition. Annals of Neurology. 63: 591-601. PMID 18360829 DOI: 10.1002/ana.21340  0.8
2008 Basso AS, Frenkel D, Quintana FJ, Costa-Pinto FA, Petrovic-Stojkovic S, Puckett L, Monsonego A, Bar-Shir A, Engel Y, Gozin M, Weiner HL. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis. The Journal of Clinical Investigation. 118: 1532-43. PMID 18340379 DOI: 10.1172/JCI33464  0.8
2008 Weiner HL. A shift from adaptive to innate immunity: A potential mechanism of disease progression in multiple sclerosis Journal of Neurology. 255: 3-11. PMID 18317671 DOI: 10.1007/s00415-008-1002-8  0.8
2008 Sayegh MH, Weiner HL. Regulating rejection with cell therapy Nature Biotechnology. 26: 191-192. PMID 18259174 DOI: 10.1038/nbt0208-191  0.8
2008 Sosunov AA, Wu X, Weiner HL, Mikell CB, Goodman RR, Crino PD, McKhann GM. Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia. 49: 53-62. PMID 18226172 DOI: 10.1111/j.1528-1167.2008.01493.x  0.8
2008 Abraham M, Karni A, Dembinsky A, Miller A, Gandhi R, Anderson D, Weiner HL. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. Journal of Autoimmunity. 30: 21-8. PMID 18191540 DOI: 10.1016/j.jaut.2007.11.007  0.8
2008 Weiner HL. Comments Neurosurgery. 62: 918. DOI: 10.1227/01.neu.0000318177.95288.cb  0.8
2004 Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, Freeman GJ. PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells. Cellular Immunology. 230: 89-98. PMID 15598424 DOI: 10.1016/j.cellimm.2004.09.004  0.8
2004 Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. The Journal of Experimental Medicine. 199: 971-9. PMID 15067033 DOI: 10.1084/jem.20031579  0.8
1999 Hohol MJ, Olek MJ, Orav EJ, Stazzone L, Hafler DA, Khoury SJ, Dawson DM, Weiner HL. Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease. Multiple Sclerosis (Houndmills, Basingstoke, England). 5: 403-9. PMID 10618696  0.8
1998 Windhagen A, Anderson DE, Carrizosa A, Balashov K, Weiner HL, Hafler DA. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis. Journal of Neuroimmunology. 91: 1-9. PMID 9846813  0.8
1998 Takashima H, Smith DR, Fukaura H, Khoury SJ, Hafler DA, Weiner HL. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients. Clinical Immunology and Immunopathology. 88: 28-34. PMID 9683547  0.8
1997 Hafler DA, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Fukaura H. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis. Annals of the New York Academy of Sciences. 835: 120-31. PMID 9616767 DOI: 10.1111/j.1749-6632.1997.tb48623.x  0.8
1997 Smith DR, Balashov KE, Hafler DA, Khoury SJ, Weiner HL. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia. Annals of Neurology. 42: 313-8. PMID 9307252 DOI: 10.1002/ana.410420307  0.8
1997 Kent SC, Fukaura H, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Oral administration of myelin induces antigen-specific TGF-beta 1-secreting T cells in multiple sclerosis patients. Annals of the New York Academy of Sciences. 815: 412-22. PMID 9186687 DOI: 10.1111/j.1749-6632.1997.tb52092.x  0.8
1997 Nussenblatt RB, Gery I, Weiner HL, Ferris FL, Shiloach J, Remaley N, Perry C, Caspi RR, Hafler DA, Foster CS, Whitcup SM. Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. American Journal of Ophthalmology. 123: 583-92. PMID 9152063  0.8
1997 Balashov KE, Smith DR, Khoury SJ, Hafler DA, Weiner HL. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proceedings of the National Academy of Sciences of the United States of America. 94: 599-603. PMID 9012830  0.8
1996 Windhagen A, Nicholson LB, Weiner HL, Kuchroo VK, Hafler DA. Role of Th1 and Th2 cells in neurologic disorders. Chemical Immunology. 63: 171-86. PMID 8934837  0.8
1996 Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. The Journal of Clinical Investigation. 98: 70-7. PMID 8690806 DOI: 10.1172/JCI118779  0.8
1996 Matsui M, Hafler DA, Weiner HL. Pilot study of oral tolerance to keyhole limpet hemocyanin in humans: down-regulation of KLH-reactive precursor-cell frequency. Annals of the New York Academy of Sciences. 778: 398-404. PMID 8611003  0.8
1996 Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis. Annals of the New York Academy of Sciences. 778: 251-7. PMID 8610978  0.8
1996 Hohol MJ, Khoury SJ, Cook SL, Orav EJ, Hafler DA, Weiner HL. Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. Annals of the New York Academy of Sciences. 778: 243-50. PMID 8610977 DOI: 10.1111/j.1749-6632.1996.tb21132.x  0.8
1995 Hafler DA, Weiner HL. Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease. Chemical Immunology. 60: 126-49. PMID 7857525  0.8
1995 Hafler DA, Weiner HL. Antigen specific therapies for the treatment of autoimmune diseases. Agents and Actions. Supplements. 47: 59-77. PMID 7785504  0.8
1995 Balashov KE, Khoury SJ, Hafler DA, Weiner HL. Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis. The Journal of Clinical Investigation. 95: 2711-9. PMID 7769110 DOI: 10.1172/JCI117973  0.8
1995 Weiner HL, Hohol MJ, Khoury SJ, Dawson DM, Hafler DA. Therapy for multiple sclerosis. Neurologic Clinics. 13: 173-96. PMID 7739502  0.8
1995 Hafler DA, Weiner HL. Immunologic mechanisms and therapy in multiple sclerosis. Immunological Reviews. 144: 75-107. PMID 7590822  0.8
1995 Hafler DA, Weiner HL. Antigen-specific therapies for the treatment of autoimmune diseases. Springer Seminars in Immunopathology. 17: 61-76. PMID 7482227  0.8
1994 Kuchroo VK, Collins M, al-Sabbagh A, Sobel RA, Whitters MJ, Zamvil SS, Dorf ME, Hafler DA, Seidman JG, Weiner HL. T cell receptor (TCR) usage determines disease susceptibility in experimental autoimmune encephalomyelitis: studies with TCR V beta 8.2 transgenic mice. The Journal of Experimental Medicine. 179: 1659-64. PMID 8163944  0.8
1994 Weiner HL, Friedman A, Miller A, Khoury SJ, al-Sabbagh A, Santos L, Sayegh M, Nussenblatt RB, Trentham DE, Hafler DA. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annual Review of Immunology. 12: 809-37. PMID 8011298 DOI: 10.1146/annurev.iy.12.040194.004113  0.8
1994 Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science (New York, N.Y.). 265: 1237-40. PMID 7520605  0.8
1994 Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. The Journal of Experimental Medicine. 179: 973-84. PMID 7509366  0.8
1993 Weiner HL, Mackin GA, Orav EJ, Hafler DA, Dawson DM, LaPierre Y, Herndon R, Lehrich JR, Hauser SL, Turel A. Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group. Neurology. 43: 910-8. PMID 8388090  0.8
1993 Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewell KL, Hafler DA, Weiner HL. Effects of oral administration of type II collagen on rheumatoid arthritis. Science (New York, N.Y.). 261: 1727-30. PMID 8378772  0.8
1993 Hafler DA, Zhang JW, LaSalle J, Donnelly C, Weiner HL, Wucherpfeffnig K. The development of antigen specific therapies for autoimmune diseases; investigations in multiple sclerosis as a paradigm for rheumatoid arthritis. Clinical and Experimental Rheumatology. 11: S39-40. PMID 7686832  0.8
1993 Oettinger HF, al-Sabbagh A, Jingwu Z, LaSalle JM, Weiner HL, Hafler DA. Biological activity of recombinant human myelin basic protein. Journal of Neuroimmunology. 44: 157-62. PMID 7685037 DOI: 10.1016/0165-5728(93)90037-Y  0.8
1993 Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science (New York, N.Y.). 259: 1321-4. PMID 7680493  0.8
1992 Hafler DA, Cohen I, Benjamin DS, Weiner HL. T cell vaccination in multiple sclerosis: a preliminary report. Clinical Immunology and Immunopathology. 62: 307-13. PMID 1541056  0.8
1992 Zhang J, Weiner HL, Hafler DA. Autoreactive T cells in multiple sclerosis. International Reviews of Immunology. 9: 183-201. PMID 1285060 DOI: 10.3109/08830189209061790  0.8
1991 Miller A, Hafler DA, Weiner HL. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 5: 2560-6. PMID 1868980  0.8
1991 Lee SJ, Wucherpfennig KW, Brod SA, Benjamin D, Weiner HL, Hafler DA. Common T-cell receptor V beta usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Annals of Neurology. 29: 33-40. PMID 1847614 DOI: 10.1002/ana.410290109  0.8
1991 Miller A, Hafler DA, Weiner HL. Immunotherapy in autoimmune diseases. Current Opinion in Immunology. 3: 936-40. PMID 1793539  0.8
1991 Hafler DA, Matsui M, Wucherpfennig KW, Ota K, Weiner HL. The potential of restricted T cell recognition of myelin basic protein epitopes in the therapy of multiple sclerosis. Annals of the New York Academy of Sciences. 636: 251-65. PMID 1724362  0.8
1991 Wucherpfennig KW, Weiner HL, Hafler DA. T-cell recognition of myelin basic protein. Immunology Today. 12: 277-82. PMID 1716903 DOI: 10.1016/0167-5699(91)90126-E  0.8
1991 Brod SA, al-Sabbagh A, Sobel RA, Hafler DA, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig. Annals of Neurology. 29: 615-22. PMID 1716432 DOI: 10.1002/ana.410290608  0.8
1991 Hafler DA, Orav J, Gertz R, Stazzone L, Weiner HL. Immunologic effects of cyclophosphamide/ACTH in patients with chronic progressive multiple sclerosis. Journal of Neuroimmunology. 32: 149-58. PMID 1672870  0.8
1991 Hafler DA, Chofflon M, Kurt-Jones E, Weiner HL. Interleukin-1 corrects the defective autologous mixed lymphocyte response in multiple sclerosis. Clinical Immunology and Immunopathology. 58: 115-25. PMID 1670583  0.8
Show low-probability matches.